[1]
S. . Boongird, “Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients”, J Nephrol Soc Thail, vol. 28, no. 4, pp. 69–70, Dec. 2022.